CN102600298B - Traditional Chinese medicine for treating lung cancer and application of the medicine - Google Patents
Traditional Chinese medicine for treating lung cancer and application of the medicine Download PDFInfo
- Publication number
- CN102600298B CN102600298B CN201210086685.7A CN201210086685A CN102600298B CN 102600298 B CN102600298 B CN 102600298B CN 201210086685 A CN201210086685 A CN 201210086685A CN 102600298 B CN102600298 B CN 102600298B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- treatment
- pulmonary carcinoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicine for treating lung cancer, which comprises the following active components by weight: 100-150 parts of toad, 10-15 parts of centipede, 10-20 parts of gecko, 10-20 parts of Astragalus root, 3-8 parts of Radix Codonopsis (Codonopsis pilosula and/or Codonopsis tangshen), 3-8 parts of Fructus Lycii, 3-8 parts of Angelica sinensis, 7-12 parts of Atractylodes macrocephala, 3-8 parts of Cryptotympana pustulata slough, 3-8 parts of Lumbricus, 2-6 parts of Prunella vulgaris, 1-5 parts of Notoginseng powder, 2-6 parts of Olibanum, 1-5 parts of myrrh, 3-8 parts of Oldenlandia diffusa, 3-8 parts of Ligustrum lucidum fruit, 1-4 parts of musk and 1-5 parts of Platycodon grandiflorum. The invention also relates to application of the traditional Chinese medicine for treating lung cancer in the preparation of a product for treating lung cancer. The traditional Chinese medicine for treating lung cancer can effectively treat lung cancer.
Description
Technical field
The present invention relates to a kind of Chinese medicine and application thereof for the treatment of pulmonary carcinoma.
Background technology
Pulmonary carcinoma is modal malignant tumor in mid-aged population, and its sickness rate is in rising trend in the whole world.Pulmonary carcinoma is the highest cancer of China's sickness rate, every year newly-increased about 400,000 people of case.If smoking and air pollution are not controlled in World Health Organization's prediction, by 2025, the newly-increased pulmonary carcinoma of China will exceed 1,000,000 examples, become the first in the world pulmonary carcinoma big country.
Pulmonary carcinoma is divided into three types substantially: small cell lung cancer, adenocarcinoma and squamous cell carcinoma.Pulmonary carcinoma is very large to mankind's harm, should find early, and surgical result is best.But general discovery is all more late, have more than 40% and be not suitable for operation, especially the function of elderly patients' airframe systems is all going down, resistance is also declining, and in the thoracic cavity that operation wound causes, negative pressure disappears, and lung tissue atrophy is subsided, closed drainage of pleural cavity stimulates etc., and side effect is very large.
Utilizing Chinese medicine is to make up the above-mentioned effective way that is not enough to improve therapeutic effect.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine and application thereof for the treatment of pulmonary carcinoma.
A kind of Chinese medicine for the treatment of pulmonary carcinoma provided by the invention, in weight portion, effective ingredient contains following component:
Bufo siccus 100-150, Scolopendra 10-15, Gekko Swinhonis 10-20, Radix Astragali 10-20, Radix Codonopsis 3-8,
Fructus Lycii 3-8, Radix Angelicae Sinensis 3-8, Rhizoma Atractylodis Macrocephalae 7-12, Periostracum Cicadae 3-8, Pheretima 3-8,
Spica Prunellae 2-6, Radix Notoginseng powder 1-5, Olibanum 2-6, Myrrha 1-5, Herba Hedyotidis Diffusae 3-8,
Fructus Ligustri Lucidi 3-8, Moschus 1-4, Radix Platycodonis 1-5.
Preferably, in weight portion, described each amounts of components is as follows:
Bufo siccus 110-130, Scolopendra 10-15, Gekko Swinhonis 10-15, Radix Astragali 13-18, Radix Codonopsis 4-6,
Fructus Lycii 4-6, Radix Angelicae Sinensis 4-6, Rhizoma Atractylodis Macrocephalae 8-10, Periostracum Cicadae 4-6, Pheretima 4-6,
Spica Prunellae 3-5, Radix Notoginseng powder 2-4, Olibanum 3-5, Myrrha 2-4, Herba Hedyotidis Diffusae 4-6,
Fructus Ligustri Lucidi 4-6, Moschus 1-3, Radix Platycodonis 2-4.
More preferably, in weight portion, described each amounts of components is as follows:
Bufo siccus 110-130, Scolopendra 10-15, Gekko Swinhonis 10-15,, the Radix Astragali 15, Radix Codonopsis 5,
Fructus Lycii 5, Radix Angelicae Sinensis 5, the Rhizoma Atractylodis Macrocephalae 9, Periostracum Cicadae 5, Pheretima 5,
Spica Prunellae 4, Radix Notoginseng powder 3, Olibanum 4, Myrrha 3, Herba Hedyotidis Diffusae 5,
Fructus Ligustri Lucidi 5, Moschus 2, Radix Platycodonis 3.
In weight portion, effective ingredient can also contain following component:
Borneolum Syntheticum 3-8, Lignum Santali Albi 3-8, Radix Inulae 3-8, Rhizoma Arisaematis (processed) 1-4.
Preferably, in weight portion,
Borneolum Syntheticum 4-6, Lignum Santali Albi 4-6, Radix Inulae 4-6, Rhizoma Arisaematis (processed) 1-3.
More preferably, in weight portion,
Borneolum Syntheticum 5, Lignum Santali Albi 5, Radix Inulae 5, Rhizoma Arisaematis (processed) 2.
The application of the Chinese medicine of the treatment pulmonary carcinoma described in the invention still further relates in the product for the preparation for the treatment of pulmonary carcinoma.
Described application examples, as being, grinds to form fine powder by all components that contains Borneolum Syntheticum, Lignum Santali Albi, Radix Inulae and Rhizoma Arisaematis (processed), packs in textile bags, makes the medicated bag that can allow people carry on the back in front and naturally drug molecule to be sucked with nose.
The medicated bag that above-mentioned application makes is also a part of the present invention.
The Chinese medicine for the treatment of pulmonary carcinoma provided by the invention can be treated pulmonary carcinoma effectively, and oral dose is very little, 10-20ml of decoction amount, and one day twice, effect was fine.The drug molecule of the prescription utilization fragrance that contains described Borneolum Syntheticum, Lignum Santali Albi, Radix Inulae and Rhizoma Arisaematis (processed) is dispersed in air, and patient enters in lung by breathing, and nutrition pneumonocyte on the one hand, increases pulmonary function; On the other hand, drug molecule directly contacts, and kills cancerous cell, recovers lung power, reaches therapeutic purposes, and effect is directly quick.
The specific embodiment
Embodiment mono-
Drug component and consumption:
Approximately 10 grams altogether of 120 grams of Bufo siccuss, Scolopendra, approximately 12 grams altogether of Gekko Swinhonis, Radix Astragali 15g, Radix Codonopsis 5g,
Fructus Lycii 5g, Radix Angelicae Sinensis 5g, Rhizoma Atractylodis Macrocephalae 9g, Periostracum Cicadae 5g, Pheretima 5g,
Spica Prunellae 4g, Radix Notoginseng powder 3g, Olibanum 4g, Myrrha 3g, Herba Hedyotidis Diffusae 5g,
Fructus Ligustri Lucidi 5g, Moschus 2g (under last 3 minutes), Radix Platycodonis 3g
The compounding method of medicine: above-mentioned medicinal 2000ml pure water is decocted to 500ml (decocting time 8 hours), be then put in refrigerator, each oral 10-20ml, one day 2 times, this survival dose is little, but effective, and patient easily accepts.
In order to upper medicine, discharge water after decoction, 1/4 of the only surplus original water yield, this effect to medicine is reasonable, and concentration is large, oral dose is little, once only takes 10-20ml, patient's taking convenience, but effect is fine, general clothes for patients is very obvious by 3-6 month effect, good storage.
Below for utilizing two cases of above-mentioned prescription and instructions of taking treatment:
Cure small cell lung cancer one example
(1) Zhao × ×, man, 48 years old, people from Siping City, northeast.Within 1986, in Changchun tumour hospital, see a doctor, be diagnosed as small cell lung cancer.Tell him to also have the life-span of some months.He does not believe, by lover, is accompanied and is come the Academy of Medical Sciences, Beijing tumour hospital, says that with doctor Changchun says that he also has the life of some months, and he says that I do not believe, just looks for you.The doctor here says: " he is said quite right,, can only be at most also the trimestral life-span here." but tell him, do not have now berth.Just in time there is the consultation of doctors of individual doctor Yao Laiwo institute in tumour hospital, says: " my Dai Niquge hospital can be in hospital." he has just come on.
Come my institute, lower ambulance just sits on the ground, can not walk, and we lift to ward with stretcher, just by our Chinese traditional treatment method, to him, treat, two months as a result healths well, three months physical recoveries better.Through the treatment of a year, leave hospital and be on home leave, to treat again after 2 courses for the treatment of, gone to work in the treatment limit, limit of being just in.
After going back, gone to work.He lover Bi Ta is little seven years old, heart disease, and in the dust, he is also not dead for his lover of result.SM, Clinical Follow-up 5 years, still survival.
(2) cure pulmonary carcinoma (squamous cell carcinoma) example:
× ×, female, Nanjing Human, is the inventor's a friend's boss's lover, can not walk at that time with descending.This friend asks whether I can treat, and I make him that the diagnosis testimonial material in hospital is mailed, and I have posted the medicine of two months to her after seeing, very good by rear effect, and her lover drives to be with her to countryside, to take a walk.It is fine that her lover incoming call is talked about medication, run low, and is her younger brother and mailorders, because be afraid of postal delivery not in time, the medicine that her younger brother got to hospital in the New Year's Eve, in person to sending back.SM, Clinical Follow-up 5 years, still survival.
Embodiment bis-
Drug component and consumption:
Approximately 15 grams altogether of 100 grams of Bufo siccuss, Scolopendra, approximately 12 grams altogether of Gekko Swinhonis, Radix Astragali 15g, Radix Codonopsis 5g,
Fructus Lycii 5g, Radix Angelicae Sinensis 5g, Rhizoma Atractylodis Macrocephalae 9g, Periostracum Cicadae 5g, Pheretima 5g,
Spica Prunellae 4g, Radix Notoginseng powder 3g, Olibanum 4g, Myrrha 3g, Herba Hedyotidis Diffusae 5g,
Fructus Ligustri Lucidi 5g, Moschus 2g, Radix Platycodonis 3g, Borneolum Syntheticum 5g, Lignum Santali Albi 5g, Radix Inulae 5g, Rhizoma Arisaematis (processed) 2g
The preparation method of medicine: above-mentioned each taste Chinese medicine is ground to form to fine powder altogether, through processing, pack in triangle cloth bag, and sew it up into smooth triangle with machine, install with a ready-made cloth bag, and have braces to carry on the back in front, available nose is naturally inhaled drug molecule and in lung, is started to cure the disease.A bag is worn 20 days, and three bags are a course for the treatment of.General lung cancer patient will be worn 3-6 the course for the treatment of can obtain good effect, and this medicated bag coordinates our oral drugs, and therapeutic effect is best together.
The Chinese medicine of this embodiment has the feature of volatilization, causing resuscitation with aromatic drugs, can be conducted and be entered focus by breathing.Because the medicine of this medicated bag is all the pure Chinese medicine of causing resuscitation with aromatic drugs, blood circulation promoting and blood stasis dispelling, numbness relieving and pain relieving, by 30 taste Chinese medicines, formed, be rare generous in the traditional Chinese medical science.These medicines after treatment, can, to discharging high amount of drug molecule in the air, allow patient enter pulmonary by breathing, reach therapeutic effect.And, between these medicines, mutually strengthen again the efficacy of a drug, can be described as the wonderful work in prescription.
Pulmonary carcinoma great Xu is divided into three kinds (certainly can also segment): small cell lung cancer, adenocarcinoma, scale cancer.We 1986 bring into use, separately add oral medicine (be the prepared oral medicine of embodiment mono-, consumption is very little, each 20ml, every day secondary), treat nearly several thousand routine lung cancer patients, effect is all fine.Once treated in this way the patient of several routine gastric cancer, reacted also good, but because inventor's energy is limited, only with all strength studied pulmonary carcinoma, thus can only illustrate this oral drugs and medicated bag remarkable to the effect of pulmonary carcinoma.
Be below two model cases:
One, cure small cell lung cancer one example
Guo × ×, man, Pekinese, suffers from small cell lung cancer, he is diagnosed as pulmonary carcinoma in 301 Hospital, but late period, without surgical engine meeting, is only had some Western medicine to him, found afterwards us, we give the liquid medicine of he oral embodiment mono-, and wear the medicated bag of embodiment bis-, and after half a year, he has gone to work again.SM, Clinical Follow-up 5 years, still survival.
Two, cure adenocarcinoma of lung one example
Youth × ×, female, Pekinese, suffers from adenocarcinoma of lung.When her lover is with her to Yuquanshan Mountain tumour hospital, she can not get off, and by her lover, embraces down car, to Hepingli traditional chinese medical science clinic at inventor place, inventor received her in hospital afterwards, the Chinese medicine of oral enforcement one, wear the medicated bag of embodiment bis-, through treatment half a year, leave hospital.When we go to her family to access afterwards, she says that she can roll over two quilts morning, has washed and has dried in the air, and then goes neighbour's to play card, and can also make quilt afternoon.SM, Clinical Follow-up 5 years, still survival.
Claims (10)
1. a Chinese medicine for the treatment of pulmonary carcinoma, is characterized in that, in weight portion, effective ingredient is following component:
Bufo siccus 100-150, Scolopendra 10-15, Gekko Swinhonis 10-20, Radix Astragali 10-20, Radix Codonopsis 3-8,
Fructus Lycii 3-8, Radix Angelicae Sinensis 3-8, Rhizoma Atractylodis Macrocephalae 7-12, Periostracum Cicadae 3-8, Pheretima 3-8,
Spica Prunellae 2-6, Radix Notoginseng powder 1-5, Olibanum 2-6, Myrrha 1-5, Herba Hedyotidis Diffusae 3-8,
Fructus Ligustri Lucidi 3-8, Moschus 1-4, Radix Platycodonis 1-5.
2. the Chinese medicine for the treatment of pulmonary carcinoma according to claim 1, is characterized in that, in weight portion, described each amounts of components is as follows:
Bufo siccus 110-130, Scolopendra 10-15, Gekko Swinhonis 10-15, Radix Astragali 13-18, Radix Codonopsis 4-6,
Fructus Lycii 4-6, Radix Angelicae Sinensis 4-6, Rhizoma Atractylodis Macrocephalae 8-10, Periostracum Cicadae 4-6, Pheretima 4-6,
Spica Prunellae 3-5, Radix Notoginseng powder 2-4, Olibanum 3-5, Myrrha 2-4, Herba Hedyotidis Diffusae 4-6,
Fructus Ligustri Lucidi 4-6, Moschus 1-3, Radix Platycodonis 2-4.
3. the Chinese medicine for the treatment of pulmonary carcinoma according to claim 1, is characterized in that, in weight portion, described each amounts of components is as follows:
Bufo siccus 110-130, Scolopendra 10-15, Gekko Swinhonis 10-15, the Radix Astragali 15, Radix Codonopsis 5,
Fructus Lycii 5, Radix Angelicae Sinensis 5, the Rhizoma Atractylodis Macrocephalae 9, Periostracum Cicadae 5, Pheretima 5,
Spica Prunellae 4, Radix Notoginseng powder 3, Olibanum 4, Myrrha 3, Herba Hedyotidis Diffusae 5,
Fructus Ligustri Lucidi 5, Moschus 2, Radix Platycodonis 3.
4. a Chinese medicine for the treatment of pulmonary carcinoma, is characterized in that, in weight portion, effective ingredient is comprised of Chinese medicine and the following component of the treatment pulmonary carcinoma described in claim 1-3 any one:
Borneolum Syntheticum 3-8, Lignum Santali Albi 3-8, Radix Inulae 3-8, Rhizoma Arisaematis (processed) 1-4.
5. the Chinese medicine of a treatment pulmonary carcinoma claimed in claim 4, is characterized in that, in weight portion,
Borneolum Syntheticum 4-6, Lignum Santali Albi 4-6, Radix Inulae 4-6, Rhizoma Arisaematis (processed) 1-3.
6. the Chinese medicine of a treatment pulmonary carcinoma claimed in claim 4, is characterized in that, in weight portion,
Borneolum Syntheticum 5, Lignum Santali Albi 5, Radix Inulae 5, Rhizoma Arisaematis (processed) 2.
7. the application of the Chinese medicine of the treatment pulmonary carcinoma described in claim 1-3 any one in the product for the preparation for the treatment of pulmonary carcinoma.
8. the application of the Chinese medicine for the treatment of pulmonary carcinoma claimed in claim 4 in the product for the preparation for the treatment of pulmonary carcinoma.
9. application according to claim 8, is characterized in that, all components is ground to form to fine powder, packs in textile bags, makes the medicated bag that can allow people carry on the back in front and naturally drug molecule to be sucked with nose.
10. the medicated bag that application claimed in claim 9 makes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210086685.7A CN102600298B (en) | 2012-03-28 | 2012-03-28 | Traditional Chinese medicine for treating lung cancer and application of the medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210086685.7A CN102600298B (en) | 2012-03-28 | 2012-03-28 | Traditional Chinese medicine for treating lung cancer and application of the medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102600298A CN102600298A (en) | 2012-07-25 |
| CN102600298B true CN102600298B (en) | 2014-04-16 |
Family
ID=46518317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210086685.7A Expired - Fee Related CN102600298B (en) | 2012-03-28 | 2012-03-28 | Traditional Chinese medicine for treating lung cancer and application of the medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102600298B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105250911A (en) * | 2015-10-28 | 2016-01-20 | 韩广成 | Traditional Chinese medicine preparation for preventing and treating cancer and preparation method thereof |
| CN105362513A (en) * | 2015-12-17 | 2016-03-02 | 邓少东 | Traditional Chinese medicine composition for treating lung cancer |
| CN105396076A (en) * | 2016-01-06 | 2016-03-16 | 青岛辰达生物科技有限公司 | Drug preparation for curing lung cancer and application thereof |
| CN107519354A (en) * | 2017-09-29 | 2017-12-29 | 南京仙草堂生物科技有限公司 | A kind of cancer therapy drug based on Scolopendra extract and centipede pseudo-ginseng |
| CN113995717A (en) * | 2021-12-22 | 2022-02-01 | 柳州市中医医院(柳州市壮医医院) | External application formula for treating cancer pain |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1742866A (en) * | 2004-08-31 | 2006-03-08 | 蔡绪旺 | Anti-cancer Chinese medicine capsule preparation |
-
2012
- 2012-03-28 CN CN201210086685.7A patent/CN102600298B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1742866A (en) * | 2004-08-31 | 2006-03-08 | 蔡绪旺 | Anti-cancer Chinese medicine capsule preparation |
Non-Patent Citations (8)
| Title |
|---|
| 《刘嘉湘扶正法治疗肺癌的经验和体会》;孙建立等;《辽宁中医杂志》;20081231;第35卷(第9期);1302-1303 * |
| 《复法大方治肺癌》;陈四清;《江苏中医药》;20041231;第25卷(第2期);34-35 * |
| 《论癌症从虚毒治疗》;章永红等;《南京中医药大学学报》;20091130;第25卷(第6期);408-411 * |
| 《论癌症治疗的三大原则》;张永红;《南京中医药大学学报》;20110131;第27卷(第1期);4-6 * |
| 孙建立等.《刘嘉湘扶正法治疗肺癌的经验和体会》.《辽宁中医杂志》.2008,第35卷(第9期),1302-1303. |
| 张永红.《论癌症治疗的三大原则》.《南京中医药大学学报》.2011,第27卷(第1期),4-6. |
| 章永红等.《论癌症从虚毒治疗》.《南京中医药大学学报》.2009,第25卷(第6期),408-411. |
| 陈四清.《复法大方治肺癌》.《江苏中医药》.2004,第25卷(第2期),34-35. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102600298A (en) | 2012-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102526474B (en) | Chinese medicine composition for treating neurasthenia | |
| CN102600298B (en) | Traditional Chinese medicine for treating lung cancer and application of the medicine | |
| CN101612349A (en) | The medicine of treatment coronary heart disease | |
| CN102813839A (en) | Compound medicine for treating cluster headache syndrome | |
| CN101391056B (en) | Medicine for treating aplastic anemia | |
| CN102579999B (en) | Medicine for treating carcinous fever and preparation method thereof | |
| CN103948888A (en) | Traditional Chinese medicinal preparation for treating neurasthenia | |
| CN107243022A (en) | Traditional Chinese medicine pill for the treatment of cancer and preparation method thereof | |
| CN102349985A (en) | Traditional Chinese medicine composition for treating chronic arrhythmias | |
| CN102125645B (en) | Traditional Chinese medicine preparation for treating osteoporosis | |
| CN103990009A (en) | Traditional Chinese medicine for treatment of type II diabetes by invigorating spleen and purging turbidness | |
| CN101564505B (en) | Chinese medicament for treating pulmonary heart disease | |
| CN100540030C (en) | A kind of topical agent for the treatment of dysmenorrhes | |
| CN102988900A (en) | Traditional Chinese medicine enema used for treating senile functional constipation | |
| CN101703660B (en) | Anti-aging medicament | |
| CN104940516A (en) | Traditional Chinese medicine composition for treating chronic aplastic anemia, and preparation method and application thereof | |
| CN105456887A (en) | Pharmaceutical for treating aplastic anemia | |
| CN101199761B (en) | Drug for treating arteriosclerosis | |
| CN104800491A (en) | Oral solution with superstrong function of improving human immunity | |
| CN104435545A (en) | Traditional Chinese medicine preparation for treating leucopenia caused by benzene poisoning | |
| CN1628820A (en) | Traditional Chinese medicinal pillow for treating cervical spondylosis and its preparing method | |
| CN103211949B (en) | Traditional Chinese medicine composition for treating gastric diseases of human body as well as preparation method and application thereof | |
| CN102512593A (en) | Traditional Chinese medicine preparation for treating aplastic anemia | |
| CN1242198A (en) | Traditional Chinese medicine capsule for treating coronary heart disease | |
| CN102319387A (en) | Traditional Chinese medicine composition for treating chronic cough |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140416 Termination date: 20150328 |
|
| EXPY | Termination of patent right or utility model |